1. Home
  2. GKOS vs SEE Comparison

GKOS vs SEE Comparison

Compare GKOS & SEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$113.41

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Logo Sealed Air Corporation

SEE

Sealed Air Corporation

HOLD

Current Price

$41.52

Market Cap

5.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
SEE
Founded
1998
1960
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
5.1B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
GKOS
SEE
Price
$113.41
$41.52
Analyst Decision
Strong Buy
Buy
Analyst Count
14
11
Target Price
$127.71
$43.50
AVG Volume (30 Days)
641.9K
4.4M
Earning Date
02-19-2026
02-24-2026
Dividend Yield
N/A
1.93%
EPS Growth
N/A
13.73
EPS
N/A
3.09
Revenue
$469,820,000.00
$5,331,600,000.00
Revenue This Year
$31.15
N/A
Revenue Next Year
$24.15
$1.16
P/E Ratio
N/A
$13.44
Revenue Growth
30.38
N/A
52 Week Low
$73.16
$22.78
52 Week High
$163.71
$44.27

Technical Indicators

Market Signals
Indicator
GKOS
SEE
Relative Strength Index (RSI) 58.14 55.70
Support Level $109.07 $41.41
Resistance Level $115.00 $41.69
Average True Range (ATR) 2.76 0.14
MACD -0.95 -0.09
Stochastic Oscillator 44.01 68.09

Price Performance

Historical Comparison
GKOS
SEE

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About SEE Sealed Air Corporation

Sealed Air is organized via two reporting segments. Food includes food packaging products like Cryovac, Darfresh, and OptiDure aimed primarily at meats. Protective includes Sealed Air's Bubble Wrap, Instapak, Jiffy mailers, and shrink film packaging systems that cater to industrial and e-commerce applications.

Share on Social Networks: